Rheumatoid arthritis of wrist with involvement of other organs and systems
ICD-10 M05.63 is a billable code used to indicate a diagnosis of rheumatoid arthritis of wrist with involvement of other organs and systems.
Rheumatoid arthritis (RA) is a chronic inflammatory autoimmune disorder primarily affecting the synovial joints, including the wrist. The pathophysiology involves the immune system mistakenly attacking the synovial membrane, leading to inflammation, pain, and eventual joint destruction. Anatomically, the wrist consists of the distal radius and ulna, along with eight carpal bones, which articulate with the metacarpals. In RA, the inflammation can extend beyond the joints, affecting other systems such as the cardiovascular, pulmonary, and renal systems. Clinically, patients may present with joint swelling, stiffness, particularly in the morning, and systemic symptoms like fatigue and malaise. The involvement of other organs can manifest as pleuritis, pericarditis, or vasculitis, complicating the clinical picture and necessitating a multidisciplinary approach to management.
Orthopedic documentation should include imaging studies (X-rays, MRIs) to assess joint damage and functional assessments to evaluate range of motion and strength.
Common scenarios include surgical interventions such as synovectomy or joint replacement due to severe joint destruction.
Documentation must detail the specific joints involved and the extent of damage to guide treatment decisions.
Rheumatologic documentation should include laboratory tests for inflammatory markers (e.g., ESR, CRP) and disease activity scores (e.g., DAS28).
Autoimmune scenarios may involve managing flares and adjusting DMARD therapy based on disease activity.
Systemic involvement must be documented, including any extra-articular manifestations.
Functional assessments should include evaluations of mobility, activities of daily living, and the need for assistive devices.
Rehabilitation scenarios may focus on restoring function post-surgery or managing chronic pain.
Mobility limitations due to joint involvement must be clearly documented to support therapy needs.
Used for joint swelling management in RA patients.
Document the joint involved, the reason for the procedure, and any therapeutic agents used.
Orthopedic and rheumatologic considerations for joint health and systemic effects.
Key documentation includes detailed descriptions of joint involvement, systemic symptoms, laboratory results indicating inflammation, and any treatments administered. Ensure that the documentation reflects the complexity of the condition, including any comorbidities.
